Topic: Cougar Biotechnology Inc.
Johnson & Johnson to acquire Cougar Biotechnology for $43 a share in cash, or $1 billionJohnson & Johnson says it will buy Cougar Biotechnology for about $1 billion in cash in a move to bulk up its cancer drug portfolio.New ...
